World News: 21:30 GMT Tuesday 13th February 2018. [Merck via Businesswire via SPi World News]
Merck NYSE MRK known as MSD outside the United States and Canada today announced that it will be stopping protocol 019 also known as the APECS study a Phase 3 study evaluating verubecestat MK-8931 an investigati onal sm...
Business Wire: 21:30 GMT Tuesday 13th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.